Kintor Pharmaceutical Limited (HKG:9939)

Kintor Pharmaceutical Revenue

Kintor Pharmaceutical had revenue of 52.04M CNY in the half year ending June 30, 2026. This brings the company's revenue in the last twelve months to 78.74M, up 616.84% year-over-year. In the year 2025, Kintor Pharmaceutical had annual revenue of 32.68M with 553.64% growth.

• Revenue (ttm): 78.74M CNY
• Revenue Growth: +616.84%
• P/S Ratio: 9.89
• Revenue / Employee: 645.39K CNY
• Employees: 122
• Market Cap: 898.73M HKD

Revenue Chart

Chart

Chart

* This company reports financials in CNY.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	32.68M	27.68M	553.64%
Dec 31, 2024	5.00M	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	34.23M	-	-

Data Source: S&P Global Market Intelligence Last updated: Aug 19, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Sep 19, 2026

Data Sources Report a data error